Silencing of BCL11A gene expression by miR-137 or disruption of BCL11A-DNMT1 (DNA methyltransferase 1) interaction reduced the number of cancer stem cells and inhibited cancer development [7]. This evidence concerns the gene DNMT1 and cancer.